• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺癌分期中的困境。

Dilemmas in lung cancer staging.

机构信息

Department of Pathology-PUH C608, University of Pittsburgh Medical Center, 200 Lothrop St., Pittsburgh, PA 15213, USA.

出版信息

Arch Pathol Lab Med. 2012 Oct;136(10):1194-7. doi: 10.5858/arpa.2012-0282-CC.

DOI:10.5858/arpa.2012-0282-CC
PMID:23020722
Abstract

The TNM staging system is the most important prognostic factor for lung cancer. The most encountered difficulties in pathologic staging of lung cancer include assessment of pleural invasion, synchronous tumor nodules, and lymph node sampling.

摘要

TNM 分期系统是肺癌最重要的预后因素。肺癌病理分期最常遇到的困难包括胸膜侵犯、同步肿瘤结节和淋巴结取样的评估。

相似文献

1
Dilemmas in lung cancer staging.肺癌分期中的困境。
Arch Pathol Lab Med. 2012 Oct;136(10):1194-7. doi: 10.5858/arpa.2012-0282-CC.
2
An update on lung cancer staging.肺癌分期的最新进展。
Adv Anat Pathol. 2010 Jan;17(1):33-7. doi: 10.1097/PAP.0b013e3181c66f15.
3
Prognostic impact of intratumoral vessel invasion in completely resected pathologic stage I non-small cell lung cancer.肿瘤内血管侵犯对完全切除的病理I期非小细胞肺癌的预后影响
J Thorac Cardiovasc Surg. 2009 Feb;137(2):429-34. doi: 10.1016/j.jtcvs.2008.07.007. Epub 2008 Sep 14.
4
Commonly encountered difficulties in pathologic staging of lung cancer.
Arch Pathol Lab Med. 2007 Jul;131(7):1016-26. doi: 10.5858/2007-131-1016-CEDIPS.
5
Visceral pleural invasion classification in non-small cell lung cancer: a proposal on the basis of outcome assessment.非小细胞肺癌脏层胸膜侵犯分类:基于预后评估的建议
J Thorac Cardiovasc Surg. 2004 Jun;127(6):1574-8. doi: 10.1016/j.jtcvs.2003.11.017.
6
Advances in the pathologic staging of lung cancer: detection of regional and systemic occult metastases.肺癌病理分期的进展:区域和全身隐匿性转移的检测
Pathology (Phila). 1996;4(1):155-68.
7
The 7th Edition of the TNM staging system for lung cancer: what the radiologist needs to know.肺癌TNM分期系统第7版:放射科医生需要了解的内容。
Radiol Clin North Am. 2012 Sep;50(5):915-33. doi: 10.1016/j.rcl.2012.06.001.
8
Is T factor of the TNM staging system a predominant prognostic factor in pathologic stage I non-small-cell lung cancer ? A multivariate prognostic factor analysis of 151 patients.TNM分期系统中的T因子是病理I期非小细胞肺癌的主要预后因素吗?对151例患者的多因素预后因素分析。
J Thorac Cardiovasc Surg. 1993 Jul;106(1):90-4.
9
[TNM staging system of lung carcinoma: historical notes, limitations and controversies].[肺癌的TNM分期系统:历史沿革、局限性及争议]
Ann Ital Chir. 1995 Jul-Aug;66(4):425-32.
10
The new tumor, node, and metastasis staging system.新的肿瘤、淋巴结和转移分期系统。
Semin Respir Crit Care Med. 2011 Feb;32(1):44-51. doi: 10.1055/s-0031-1272868. Epub 2011 Apr 15.

引用本文的文献

1
Establishment of a non-small-cell lung cancer-liver metastasis patient-derived tumor xenograft model for the evaluation of patient-tailored chemotherapy.建立非小细胞肺癌肝转移患者来源肿瘤异种移植模型,用于评估患者个体化化疗。
Biosci Rep. 2019 Jul 5;39(7). doi: 10.1042/BSR20182082. Print 2019 Jul 31.
2
Gross handling of pulmonary resection specimen: maintaining the 3-dimensional orientation.肺切除标本的大体处理:保持三维方向。
J Thorac Dis. 2019 Jan;11(Suppl 1):S37-S44. doi: 10.21037/jtd.2018.12.36.
3
Synchronous non small cell lung cancer nodules treated with stereotactic body radiation therapy (SBRT).
采用立体定向体部放射治疗(SBRT)治疗的同步性非小细胞肺癌结节。
J Radiosurg SBRT. 2014;3(1):81-88.